Filter
8981
Filtered Results: 8981
Text search:
Disease
Analyse
Featured
Recommendations
751
New Publications
2176
Language
Document type
No document type
4752
Studies & Reports
1820
Guidelines
1177
Manuals
420
Strategic & Response Plan
375
Fact sheets
201
Training Material
97
Situation Updates
75
Resource Platforms
28
Infographics
13
Brochures
9
Dashboards/Maps
7
Online Courses
7
Countries / Regions
Global
444
India
294
Kenya
243
Western and Central Europe
186
Sierra Leone
175
South Africa
173
Ethiopia
168
Uganda
153
Nigeria
151
Africa
151
Nepal
149
Liberia
148
Latin America and the Carribbean
142
Malawi
128
Zambia
119
Rwanda
117
Myanmar / Burma
112
Tanzania
111
Congo, Democratic Republic of
108
Bangladesh
108
Ukraine
94
Ghana
92
Syria
89
Eastern Europe
79
Russia
75
Brazil
74
Mozambique
73
Senegal
68
Zimbabwe
64
Guinea
64
Germany
63
Namibia
62
Asia
60
South Sudan
59
Philippines
56
South–East Asia Region
56
Lesotho
55
West and Central Africa
52
Haiti
51
Indonesia
50
East and Southern Africa
49
Cambodia
46
Yemen
46
Cameroon
45
Middle East and North Africa
42
Burkina Faso
41
Botswana
36
Eastern Europe and Central Asia
32
Pakistan
30
Colombia
27
Venezuela
25
Central African Republic
25
Madagascar
25
Benin
24
Eswatini/ Swaziland
24
Afghanistan
23
Mali
22
Sudan
21
Peru
20
Côte d’Ivoire / Ivory Coast
18
Thailand
17
Angola
17
Tajikistan
16
Chile
16
Somalia
16
USA
15
Western Pacific Region
15
China
14
Iraq
14
Albania
13
Jordan
13
Paraguay
13
Argentina
13
Moldova
13
Guinea-Bissau
12
North America
12
Lebanon
12
Vietnam
12
Chad
12
Togo
10
Niger
10
Ecuador
10
Spain
9
Sri Lanka
9
Laos
8
Armenia
8
Georgia
8
Turkey
7
Kyrgyzstan
7
Burundi
7
Southern Africa
7
Bolivia
7
Papua New Guinea
7
North Macedonia
6
Mexico
6
Kazakhstan
6
France
6
United Kingdom
6
Egypt
6
Palestine
6
Poland
6
Libya
6
Timor Leste/ East Timor
5
Gambia
5
Iran
5
Romania
5
Canada
4
Hungary
4
Saudi Arabia
4
Gabon
4
Turkmenistan
4
Jamaica
4
Tunisia
4
Belarus
4
Honduras
4
El Salvador
3
Serbia
3
Estonia
3
Congo-Brazzaville
3
Uzbekistan
3
Malaysia
3
Mongolia
3
Japan
3
Mauritius
3
Portugal
3
Greece
3
Bhutan
3
North Korea
2
Fiji
2
Vanuatu
2
Morocco
2
Qatar
2
Bulgaria
2
Italy
2
Uruguay
2
Belgium
2
Bosnia and Herzegovina
2
Djibouti
2
Slovakia
2
Guatemala
2
Switzerland
1
Singapore
1
Mauritania
1
Dominican Republic
1
Croatia
1
Lithuania
1
Ireland
1
Denmark
1
Maldives
1
Algeria
1
Morocco
1
Azerbaijan
1
Israel
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
3229
Clinical Guidelines
681
Public Health
563
Key Resources
477
Women & Child Health
363
Capacity Building
113
Pharmacy & Technologies
102
Toolboxes
COVID-19
951
HIV
678
Mental Health
639
TB
549
Planetary Health
357
NTDs
324
Rapid Response
311
AMR
307
Ebola & Marburg
290
NCDs
239
Disability
229
Caregiver
199
Conflict
191
Global Health Education
157
Health Financing Toolbox
132
Pharmacy
131
Refugee
123
Natural Hazards
109
Cholera
66
Zika
63
Polio
58
Specific Hazards
44
Social Ethics
25
Malaria
20
Typhoon
6
South Sudan
2
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
This study examines the gendered impacts of the Ebola virus disease (EVD) in Liberia in the largest outbreak of EVD ever recorded. The findings are based on an extensive two-week desk study and one-week participatory field study conducted in January 2015 in the cities of Monrovia and Buchanan in Lib...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Emerging Infectious Diseases Vol. 16, No. 5, May 2010
The coronavirus disease 2019 (COVID-19) pandemic has created a global and gendered crisis that is compounding existing inequalities and disproportionately affecting girls and women. Emerging evidence from the COVID-19 crisis in 2020 shows school closures, disruptions in essential services and rising...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The materials focus on promoting healthy eating habits and reducing risk factors for non-communicable diseases such as obesity, diabetes, and heart disease. They emphasize actions to limit sugar, salt, and fat intake, including policy recommendations for eliminating trans-fats, reducing saturated fa...
The NICE guideline "Hypertension in Adults: Diagnosis and Management" outlines recommendations for diagnosing and managing hypertension in adults over 18, including those with type 2 diabetes. It emphasizes accurate blood pressure measurement, recommending ambulatory or home monitoring to confirm di...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Stop TB Communicable Diseases
Urogenital schistosomiasis is a common neglected tropical disease in many rural communities in African countries, with patches of infection in the Eastern Mediterranean Region. Globally, an estimated 239 million people are currently infected, with burden estimated at more than 3.5 million disability...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
